Suppr超能文献

长期胺碘酮治疗对甲状腺功能的影响。

Effects of long-term amiodarone treatment on thyroid function.

作者信息

Rodriguez-Espinosa J, Ordoñez-Llanos J, Solans M D, Rajmil H O, Lopez A

出版信息

Int J Clin Pharmacol Res. 1984;4(1):53-9.

PMID:6432715
Abstract

Serum determinations of total T4, total T3, reverse T3, free T3 index, free T4, free T4 index, TBG, T4/TBG ratio, TSH and cholesterol were carried out on 18 euthyroid patients with coronary heart disease. Serum samples were obtained before treatment and after 15 days, 2, 4, 6, 8, 10, 12, 14 and 16 months of treatment with amiodarone (400 mg/day). Patients were divided into two groups, according to patterns of TSH response to thyrotrophin-releasing hormone (TRH): (I) patients with normal responses (n = 12), and (II) patients with subnormal responses (n = 6). Patients of group I showed total T4, free T4 and reverse T3 increments and total T3 and free T3 index decreases, whereas patients of group II were distinguished by the absence of T3 decreases and a rise in free T4 levels that showed a significant correlation with a drop in serum cholesterol (r = -0.767; p. less than 0.001). No patient of either group showed clinical signs of thyroid dysfunction. These results show that the appearance of hormonal patterns of hyperthyroidism is unpredictable and very frequent in patients with no previous thyroid abnormalities undergoing long-term treatment with the drug.

摘要

对18例患有冠心病的甲状腺功能正常的患者进行了血清总T4、总T3、反T3、游离T3指数、游离T4、游离T4指数、甲状腺素结合球蛋白(TBG)、T4/TBG比值、促甲状腺激素(TSH)和胆固醇的测定。在使用胺碘酮(400毫克/天)治疗前以及治疗15天、2、4、6、8、10、12、14和16个月后采集血清样本。根据TSH对促甲状腺激素释放激素(TRH)的反应模式,将患者分为两组:(I)反应正常的患者(n = 12),以及(II)反应低于正常水平的患者(n = 6)。第一组患者表现出总T4、游离T4和反T3升高,总T3和游离T3指数降低,而第二组患者的特点是T3没有降低,游离T4水平升高,且与血清胆固醇下降呈显著相关性(r = -0.767;p小于0.001)。两组患者均未出现甲状腺功能障碍的临床体征。这些结果表明,在没有既往甲状腺异常的患者中,接受该药物长期治疗时,甲状腺功能亢进激素模式的出现是不可预测的,且非常常见。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验